Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.1B | 1.3B | 1.2B | 1.1B |
Cost of revenue | 750.2M | 897.6M | 901.0M | 775.6M |
Gross profit | 350.9M | 378.5M | 331.3M | 302.7M |
Operating expense | ||||
Research & development | 23.4M | 21.7M | 20.8M | 15.3M |
Selling general and admin | 193.0M | 22.9M | 266.6M | 63.6M |
Other operating expenses | 4.9M | 3.8M | 3.6M | 3.3M |
Operating income | 131.8M | 115.7M | 146.0M | 123.6M |
Non operating interest income | ||||
Income | 2.2M | 2.6M | 2.1M | 2.7M |
Expense | 8.8M | 10.4M | 10.0M | 9.2M |
Other income expense | — | — | — | — |
Pretax income | 130.8M | 127.1M | 179.4M | 117.0M |
Tax provision | 28.4M | 12.7M | 31.9M | 27.3M |
Net income | 102.4M | 114.3M | 147.5M | 89.6M |
Basic EPS | 0.3 | — | — | — |
Diluted EPS | 0.3 | — | — | — |
Basic average shares | 294.6M | — | — | — |
Diluted average shares | 302.7M | — | — | — |
EBITDA | 144.2M | 138.5M | 190.2M | 138.2M |
Net income from continuing op. | — | — | — | — |
Minority interests | -11.2M | -2.5M | -7.9M | -3.4M |
Preferred stock dividends | 0 | 0 | 0 | 0 |